IPRIPR2023-00099Institution Denied
Mylan Pharmaceuticals Inc. et al.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 10857205.
Type
IPR
Filed
Oct 28, 2022
Instituted
Mar 1, 2023
Decided
Mar 1, 2023
Patent
Application
16055847
Inventor
George D. Yancopoulos
Granted
Dec 8, 2020
01
Timeline
3 milestones
2022-10-28Petition filed
2023-03-01Institution
2023-03-01Terminated
02
Parties & counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Counsel
Molino, Paulet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Brausa, Adamet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →